BCIP Life Sciences Associates, LP, 10% Owner, Director at Aptinyx Inc. (APTX), bought 3,333,333 shares at $3.00 ($10.0M) on 2020-10-26, disclosed to the SEC on 2020-10-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |